Castillo P E, Salin P A, Weisskopf M G, Nicoll R A
Department of Cellular and Molecular Pharmacology, University of California at San Francisco 94143-0450, USA.
J Neurosci. 1996 Oct 1;16(19):5942-50. doi: 10.1523/JNEUROSCI.16-19-05942.1996.
Extracellular field potential recordings from the CA3 region in guinea pig hippocampal slices were used to study the release and action of dynorphin at the mossy fiber synapse. Dynorphin A(1-17) or U69593 inhibited mossy fiber synaptic responses in preparations in which the CA3 region was surgically isolated from the rest of the hippocampus. This inhibition was completely reversed by the kappa 1 selective antagonist nor-BNI, thus establishing the presence of functional kappa 1 receptors in CA3. Inhibitory effects of dynorphin on mossy fiber responses were unaltered in the presence of the N- or P-type Ca2+ channel blockers, omega-CgTx or omega-Aga IVA, respectively. This indicates that the action of dynorphin is independent of the particular type of Ca2+ channel that mediates transmitter release at the mossy fiber terminal. Heterosynaptic inhibition of mossy fiber responses was observed in the presence of nifedipine, omega-CgTx, or omega-Aga IVA, indicating that dynorphin release does not depend specifically on L-, N-, or P-type Ca2+ channels. The blockade of heterosynaptic inhibition by the membrane-permeant Ca2+ chelator EGTA-AM suggests the involvement of a slow Ca(2+)-dependent process in dynorphin release. On the basis of a variety of experimental evidence, we propose that the time course of heterosynaptic inhibition is determined primarily by the time course of clearance of dynorphin in the extracellular space.
利用豚鼠海马切片CA3区的细胞外场电位记录来研究强啡肽在苔藓纤维突触处的释放及作用。在将CA3区与海马其余部分手术分离的标本中,强啡肽A(1 - 17)或U69593抑制了苔藓纤维突触反应。κ1选择性拮抗剂nor - BNI可完全逆转这种抑制作用,从而证实CA3区存在功能性κ1受体。在分别存在N型或P型Ca2+通道阻滞剂ω - CgTx或ω - Aga IVA的情况下,强啡肽对苔藓纤维反应的抑制作用未改变。这表明强啡肽的作用独立于介导苔藓纤维终末递质释放的特定类型的Ca2+通道。在硝苯地平、ω - CgTx或ω - Aga IVA存在的情况下,观察到苔藓纤维反应的异突触抑制,表明强啡肽的释放并不特别依赖于L型、N型或P型Ca2+通道。膜通透性Ca2+螯合剂EGTA - AM对异突触抑制的阻断表明,强啡肽释放涉及一个缓慢的Ca(2+)依赖性过程。基于各种实验证据,我们提出异突触抑制的时间进程主要由细胞外空间中强啡肽清除的时间进程决定。